Major drug resistance mutations to HIV-1 protease inhibitors (PI) among patients exposed to PI class failing antiretroviral therapy in São Paulo State, Brazil.

MLA

Soldi, Giselle de Faria Romero, et al. “Major Drug Resistance Mutations to HIV-1 Protease Inhibitors (PI) among Patients Exposed to PI Class Failing Antiretroviral Therapy in São Paulo State, Brazil.” PLoS ONE, vol. 14, no. 10, Oct. 2019, pp. 1–15. EBSCOhost, https://doi.org/10.1371/journal.pone.0223210.

APA

Soldi, G. de F. R., Ribeiro, I. C., Ahagon, C. M., Coelho, L. P. O., Cabral, G. B., Lopes, G. I. S. L., Ferreira, J. L. de P., Brígido, L. F. de M., & null, null. (2019). Major drug resistance mutations to HIV-1 protease inhibitors (PI) among patients exposed to PI class failing antiretroviral therapy in São Paulo State, Brazil. PLoS ONE, 14(10), 1–15. https://doi.org/10.1371/journal.pone.0223210

Chicago

Soldi, Giselle de Faria Romero, Isadora Coutinho Ribeiro, Cintia Mayumi Ahagon, Luana Portes Ozório Coelho, Gabriela Bastos Cabral, Giselle Ibette Silva López Lopes, João Leandro de Paula Ferreira, Luís Fernando de Macedo Brígido, and null null. 2019. “Major Drug Resistance Mutations to HIV-1 Protease Inhibitors (PI) among Patients Exposed to PI Class Failing Antiretroviral Therapy in São Paulo State, Brazil.” PLoS ONE 14 (10): 1–15. doi:10.1371/journal.pone.0223210.